Home
Portfolio
Strategy
Team
News
Contact
Investor Login
Home
Portfolio
Strategy
Team
News
Contact
Discovery Life Sciences and Scientist.com Partner to Advance Liquid Biopsy Development and Immunotherapy Research
Read Article
News
2020
2019
Archive
December 4, 2020
Discovery Life Sciences and Scientist.com Partner to Advance Liquid Biopsy Development and Immunotherapy Research
November 30, 2020
Kinaset Therapeutics Launches with a $40M Series A Financing to Develop Novel Therapeutics for Respiratory Diseases and an Exclusive Global License Agreement with Vectura Group for KN-002 (VR588), a Novel Anti-Inflammatory
November 30, 2020
Cidara Therapeutics to Present New Clinical Data for Rezafungin at ESICM LIVES 2020
November 30, 2020
Aprea Therapeutics Receives FDA Fast Track Designation for Eprenetapopt in the Treatment of TP53 Mutant Acute Myeloid Leukemia (AML)
November 19, 2020
Vor Biopharma Promotes Tirtha Chakraborty to Chief Scientific Officer
November 19, 2020
Pear Therapeutics and Health Transformation Alliance Join in Providing Access for reSET® and reSET-O® to Self-Insured Employers
November 17, 2020
Pear Therapeutics Launches Somryst™ for Chronic Insomnia Via an End-To-End Virtual Care Experience
November 12, 2020
ChristianaCare Teams with Pear Therapeutics to Bring Patients Access to New Therapeutic Class of FDA-Authorized Prescription Digital Therapeutics for Treatment of Substance Use Disorders
November 11, 2020
Vor Biopharma Announces Exclusive License of Clinical-Stage CD33 CAR-T from National Cancer Institute
November 10, 2020
Rallybio Announces First-in-Human Dosing in RLYB211 Phase 1/2 Study
1
2
3
…
13
Next Page »
